Med BioGene, Inc.
Similar to: EpiStem Holdings Plc
Med BioGene, Inc. operates as a life science company which focuses on managing the license and rights to GeneFx Lung, a proprietary gene expression-based test for early-stage non-small-cell lung cancer. GeneFx Lung is expected to provide better-informed and personalized treatment decisions to assist in the selection of patients for adjuvant chemotherapy. Med BioGene was founded on April 28, 2006 and is headquartered in Vancouver, Canada.